Oncology Xagena
The treatment with Letrozole ( Femara ) of postmenopausal women with early breast cancer prolonged disease-free survival by reducing the risk of recurrence an additional 19% over that offered by Tamox ...
Italian researchers found that high-risk breast cancer patients do not appear to have a higher risk of relapse than the general breast cancer population during the first two years after diagnosis, unl ...
Medicines and Healthcare products Regulatory Agency ( MHRA ) in the United Kingdom has granted a new indication for Arimidex ( Anastrozole ). MHRA has acted as the Reference Member State for the Eur ...
A study, published in The Lancet, demonstrated that switching treatment to the drug Anastrozole ( Arimidex ) after two years of Tamoxifen ( Nolvadex ) can improve event-free survival for postmenopausa ...
The complete analysis of data from a trial of the drug Letrozole ( Femara ) confirms earlier reports that the drug reduced the recurrence of breast cancer in women previously treated with Tamoxifen ( ...
A study showed that the survival benefits of longer-term therapy using Tamoxifen ( Nolvadex ) may take at least nine years to develop. A long-term study evaluating two versus five-year treatment wi ...
Early detection through screening mammography and improved adjuvant treatment have contributed almost equally to the substantial decrease in breast cancer death rates over the past 10 to 15 years, res ...
Gamma-linolenic acid ( GLA ), a substance in evening primrose oil and several other plant oils used in herbal medicine, inhibits action of Her-2/neu, a cancer gene that is responsible for almost 30 pe ...
The FDA ( U.S. Food and Drug Administration ) approved Aromasin ( Exemestane tablets ) for adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer following two- ...
Few women with invasive breast cancer who are treated with lumpectomy, radiation and five years of Tamoxifen would benefit from taking an aromatase inhibitor after Tamoxifen. " A randomized study i ...
Researchers at the Fox Chase Cancer Center said the sequence of Tamoxifen ( Nolvadex ) and radiation following lumpectomy for early-stage breast cancer patients does not affect disease control, survi ...
Debate exists on how many cancer deaths are preventable in principle - estimates range from 50 percent to 80 percent - but most researchers agree that tobacco use ( mostly smoking ) accounts for the m ...
Researchers at University of Michigan and Mayo Clinic found that Tamoxifen may not be as effective for women who inherit a common genetic variation. The genetic variation affects the level of a cruc ...
A large-scale study on women with breast cancer found a 25 percent increase in the risk of developing a new non-breast cancer compared to women without cancer. Breast cancer is the most common canc ...
A laboratory study has uncovered new details about how estrogen can activate natural pathways that kill certain breast cancer cells or tumors. The results raise the possibility that estrogen therapy ...
